000			02106 a2200541 4500
005			20250516182518.0
264		0	_c20140303
008			201403s 0 0 eng d
022			_a1521-0103
024	7		_a10.1124/jpet.113.210435 _2doi
040			_aNLM _beng _cNLM
100	1		_aMa, Jiacheng
245	0	0	_aHeat shock protein 70 is necessary to improve mitochondrial bioenergetics and reverse diabetic sensory neuropathy following KU-32 therapy. _h[electronic resource]
260			_bThe Journal of pharmacology and experimental therapeutics _cFeb 2014
300			_a281-92 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aCells, Cultured
650	0	4	_aDiabetes Mellitus, Type 1 _xcomplications
650	0	4	_aDiabetes Mellitus, Type 2 _xcomplications
650	0	4	_aDiabetic Neuropathies _xprevention & control
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aGanglia, Spinal _xdrug effects
650	0	4	_aHSP70 Heat-Shock Proteins _xgenetics
650	0	4	_aHypoglycemic Agents _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMice, Knockout
650	0	4	_aMice, Transgenic
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aMitochondrial Dynamics _xdrug effects
650	0	4	_aNeuritis _xprevention & control
650	0	4	_aNeurons _xdrug effects
650	0	4	_aNeuroprotective Agents _xadministration & dosage
650	0	4	_aNovobiocin _xadministration & dosage
650	0	4	_aOxidative Phosphorylation _xdrug effects
650	0	4	_aSensory Receptor Cells _xdrug effects
700	1		_aFarmer, Kevin L
700	1		_aPan, Pan
700	1		_aUrban, Michael J
700	1		_aZhao, Huiping
700	1		_aBlagg, Brian S J
700	1		_aDobrowsky, Rick T
773	0		_tThe Journal of pharmacology and experimental therapeutics _gvol. 348 _gno. 2 _gp. 281-92
856	4	0	_uhttps://doi.org/10.1124/jpet.113.210435 _zAvailable from publisher's website
999			_c23295368 _d23295368